These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28349445)

  • 41. [Application of octrestatin in the treatment of patients with acute pancreatitis].
    Riazanov DIu
    Klin Khir; 2005 Sep; (9):15-7. PubMed ID: 16445037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Asparaginase-associated pancreatitis in children.
    Raja RA; Schmiegelow K; Frandsen TL
    Br J Haematol; 2012 Oct; 159(1):18-27. PubMed ID: 22909259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of 2 days versus 5 days of octreotide infusion along with endoscopic therapy in preventing early rebleed from esophageal varices: a randomized clinical study.
    Rengasamy S; Ali SM; Sistla SC; Lakshmi CP; Harichandra Kumar KT
    Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):386-92. PubMed ID: 25874510
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute haemorrhagic pancreatitis following L-asparaginase therapy in acute lymphoblastic leukaemia --a case report.
    Tan CL; Chiang SP; Wee KP
    Singapore Med J; 1974 Dec; 15(4):278-82. PubMed ID: 4533158
    [No Abstract]   [Full Text] [Related]  

  • 45. L-asparaginase-induced pancreatitis in children with acute lymphoblastic leukemia: is allopurinol protective?
    Muwakkit S; Saab R; Yazbeck N; Samia L; Abboud MR
    Pediatr Hematol Oncol; 2010 Sep; 27(6):496-501. PubMed ID: 20578808
    [No Abstract]   [Full Text] [Related]  

  • 46. Serial Ultrasound Monitoring for Early Recognition of Asparaginase Associated Pancreatitis in Children With Acute Lymphoblastic Leukemia.
    Raja RA; Schmiegelow K; Henriksen BM; Leth Frandsen T
    Pediatr Hematol Oncol; 2015; 32(7):474-81. PubMed ID: 26270775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Incidence of Hypersensitivity Reactions to Pegylated Asparaginase in Children With Acute Lymphoblastic Leukemia: A City-wide Experience.
    Alrazzak M; Beaupin LK; Kinyoun P; Barth M
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):e16-20. PubMed ID: 26558809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
    Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
    Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase.
    Flores-Calderón J; Exiga-Gonzaléz E; Morán-Villota S; Martín-Trejo J; Yamamoto-Nagano A
    J Pediatr Hematol Oncol; 2009 Oct; 31(10):790-3. PubMed ID: 19770681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Initial experience with octreotide in the pediatric population.
    Lam JC; Aters S; Tobias JD
    Am J Ther; 2001; 8(6):409-15. PubMed ID: 11704779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toxicity of L-asparginase in children with advanced leukemia.
    Land VJ; Sutow WW; Fernbach DJ; Lane DM; Williams TE
    Cancer; 1972 Aug; 30(2):339-47. PubMed ID: 4626307
    [No Abstract]   [Full Text] [Related]  

  • 52. Octreotide and post-ERCP pancreatitis.
    Kaya E
    Gastrointest Endosc; 2007 Aug; 66(2):420-1; author reply 421-2. PubMed ID: 17643727
    [No Abstract]   [Full Text] [Related]  

  • 53. Acute pancreatitis in association with L-asparaginase therapy: report of one case.
    Yang CM; Hsieh YL; Hwang B
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jan; 51(1):74-7. PubMed ID: 8384060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acid-suppressing Drugs and a Low 1 Level of Antithrombin as Risk Factors for L-Asparaginase-associated Pancreatitis: A Case-control Study in the Japan Association of Childhood Leukemia Study (JACLS).
    Hashii Y; Yoshida M; Hara J; Nishimura S; Yumura-Yagi K; Horibe K; Nakahata T
    J Pediatr Hematol Oncol; 2018 Jul; 40(5):374-378. PubMed ID: 29697579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
    Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK;
    Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical manifestation of toxic pancreas lesion in children with hematopoietic malignancies].
    Balcerska A; Maciejka-Kapuścińska L; Kosiak W
    Wiad Lek; 1998; 51 Suppl 4():90-6. PubMed ID: 10731949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Application of octreotide in patients with acute pancreatitis].
    Shor NA; Levina VP; Ioffe IV; Andreeva IV; Chumak IuF; Zhadanov VI; Zelenyĭ II
    Klin Khir; 2004 Feb; (2):15-7. PubMed ID: 15124466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia.
    Soyer OU; Aytac S; Tuncer A; Cetin M; Yetgin S; Sekerel BE
    J Allergy Clin Immunol; 2009 Apr; 123(4):895-9. PubMed ID: 19081614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
    Dinndorf PA; Gootenberg J; Cohen MH; Keegan P; Pazdur R
    Oncologist; 2007 Aug; 12(8):991-8. PubMed ID: 17766659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.